GATA3 and neoplasm: Whether GATA3 mutations are true oncogenic drivers is also an open question: while some in vitro and in vivo data suggest a tumor-promoting function [6, 8, 15], in general they are associated with longer survival [2] and better response to endocrine therapy [16].